Fewer experiments.
More insight.
We build intelligent automation platforms that accelerate chemical process development.
Our tools reduce R&D, manufacturing, and commercial deployment costs for the pharmaceutical, critical minerals, and chemical industries.
Our
Company
Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. We build and deploy new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. Our aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.
The Team
Our award-winning scientific leadership includes a 2-time Nobel Prize Winner in Chemistry.
We have collectively authored over 450 academic publications and 34 patents.
PARTNERS
& CLIENTS
We partner with scientific instrumentation, pharmaceutical, mining and consulting engineering companies to resolve industry-driven challenges.
SCIENTIFIC
INSTRUMENTATION
COMPANIES
PHARMACEUTICAL
COMPANIES
MINING
COMPANIES
CONSULTING
ENGINEERING
COMPANIES
GOVERNMENT
AND ACADEMIA
BECOME A PARTNER!
Company News
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
April 13, 2026 — Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues.
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
March 23, 2026 — Dr. Hawkins will contribute to the development of automated reaction sampling technology and Self-Driving Labs.
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
March 16, 2026 — The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs
Telescope Strengthens Investor Communications Strategy
March 12, 2026 — Telescoped has rescoped previously announced digital marketing agreements
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
February 23, 2026 — Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding...
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
January 30, 2026 — The Company generated revenues of $2.7 million during this period.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
January 27, 2026 — The Company is pleased to provide an update on the progress of its lithium processing...
Telescope Innovations Plans Expansion of DirectInject-LC™ Technology Ecosystem to Fuel the Physical AI Revolution
January 20, 2026 — Telescope is currently developing two new advanced analytical versions: DirectInject-IC™, and DirectInject-ICP™.
